C. Bergeron

3.3k total citations · 1 hit paper
44 papers, 2.1k citations indexed

About

C. Bergeron is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, C. Bergeron has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Neurology and 13 papers in Physiology. Recurrent topics in C. Bergeron's work include Alzheimer's disease research and treatments (12 papers), Prion Diseases and Protein Misfolding (6 papers) and Skin and Cellular Biology Research (5 papers). C. Bergeron is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Prion Diseases and Protein Misfolding (6 papers) and Skin and Cellular Biology Research (5 papers). C. Bergeron collaborates with scholars based in Canada, United States and France. C. Bergeron's co-authors include D. R. Crapper McLachlan, K. A. Jellinger, Kálmán Kovács, Anthony E. Lang, Michael S. Pollanen, Luitgard Weyer, L. Wong, Carol F. Lippa, Dennis W. Dickson and Irene Litvan and has published in prestigious journals such as Science, Neurology and Annals of Neurology.

In The Last Decade

C. Bergeron

42 papers receiving 2.0k citations

Hit Papers

Office of Rare Diseases Neuropathologic Criteria for Cort... 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bergeron Canada 24 813 788 584 472 385 44 2.1k
Matthew D. Cykowski United States 27 787 1.0× 593 0.8× 362 0.6× 258 0.5× 318 0.8× 59 2.0k
Ryder P. Gwinn United States 24 979 1.2× 298 0.4× 609 1.0× 817 1.7× 268 0.7× 41 2.3k
Marion L. C. Maat–Schieman Netherlands 34 1.2k 1.5× 1.6k 2.0× 1.5k 2.6× 793 1.7× 501 1.3× 57 3.4k
Cristina Januário Portugal 23 717 0.9× 257 0.3× 570 1.0× 485 1.0× 246 0.6× 70 1.5k
Sara Hall Sweden 26 1.9k 2.4× 1.1k 1.4× 517 0.9× 661 1.4× 721 1.9× 46 3.1k
John G. J. M. Bol Netherlands 29 459 0.6× 495 0.6× 554 0.9× 668 1.4× 620 1.6× 67 2.2k
Er‐Yun Chen United States 19 799 1.0× 361 0.5× 1.2k 2.0× 1.6k 3.3× 208 0.5× 28 2.8k
Philippe G. Vallet Switzerland 23 128 0.2× 634 0.8× 636 1.1× 466 1.0× 340 0.9× 48 1.7k
Francesco Roselli Germany 25 851 1.0× 585 0.7× 649 1.1× 664 1.4× 314 0.8× 78 2.2k
Philippe Couratier France 28 2.0k 2.4× 407 0.5× 635 1.1× 598 1.3× 458 1.2× 80 2.6k

Countries citing papers authored by C. Bergeron

Since Specialization
Citations

This map shows the geographic impact of C. Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bergeron more than expected).

Fields of papers citing papers by C. Bergeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bergeron. The network helps show where C. Bergeron may publish in the future.

Co-authorship network of co-authors of C. Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bergeron. A scholar is included among the top collaborators of C. Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bergeron. C. Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Minor, Philip D., C. Bergeron, Luisa Gregori, et al.. (2004). Standards for the assay of Creutzfeldt–Jakob disease specimens. Journal of General Virology. 85(6). 1777–1784. 34 indexed citations
2.
3.
Sutcliffe, Terry, et al.. (2003). First case of variant Creutzfeldt-Jakob disease in Canada.. PubMed. 29(13). 117–20. 8 indexed citations
4.
Dickson, Dennis W., C. Bergeron, Steven S. Chin, et al.. (2002). Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration. Journal of Neuropathology & Experimental Neurology. 61(11). 935–946. 503 indexed citations breakdown →
5.
Rozmahel, Richard, Jean Huang, F. Chen, et al.. (2002). Normal brain development in PS1 hypomorphic mice with markedly reduced γ-secretase cleavage of βAPP. Neurobiology of Aging. 23(2). 187–194. 39 indexed citations
6.
Westaway, David, Christopher Janus, M. Azhar Chishti, et al.. (2002). Aβ-immunization reduces learning impairment and amyloid plaque burden in an animal model of Alzheimer's disease. European Neuropsychopharmacology. 12. 98–98. 1 indexed citations
7.
Pollanen, Michael S. & C. Bergeron. (2000). Modeling of a periodic instability in paired helical filaments reveals an axial repeat. Acta Neuropathologica. 99(5). 534–538. 2 indexed citations
8.
Bergeron, C., et al.. (1997). Cortical Degeneration in Progressive Supranuclear Palsy. A Comparison with Cortical-Basal Ganglionic Degeneration. Journal of Neuropathology & Experimental Neurology. 56(6). 726–734. 65 indexed citations
9.
Bergeron, C., et al.. (1997). Erythrocyte spermine levels: a prognostic parameter in childhood common acute lymphoblastic leukemia. Leukemia. 11(1). 31–36. 15 indexed citations
10.
Bergeron, C., Michael S. Pollanen, Luitgard Weyer, Sandra E. Black, & Anthony E. Lang. (1996). Unusual clinical presentations of cortical‐basal ganglionic degeneration. Annals of Neurology. 40(6). 893–900. 83 indexed citations
11.
Lippa, Carol F., Ann M. Saunders, Thomas W. Smith, et al.. (1996). Familial and sporadic Alzheimer's disease. Neurology. 46(2). 406–412. 89 indexed citations
12.
Bergeron, C., C N Petrunka, Luitgard Weyer, & Michael S. Pollanen. (1996). Altered neurofilament expression does not contribute to Lewy body formation.. PubMed. 148(1). 267–72. 16 indexed citations
13.
Pollanen, Michael S., Peter Markiewicz, M. Cynthia Goh, & C. Bergeron. (1995). Alzheimer paired helical filaments: a comparison with the twisted ribbon model. Acta Neuropathologica. 90(2). 194–197. 9 indexed citations
14.
Pollanen, Michael S., C. Bergeron, & Luitgard Weyer. (1994). Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments. Acta Neuropathologica. 88(1). 1–6. 41 indexed citations
15.
Pollanen, Michael S., C. Bergeron, & Luitgard Weyer. (1993). Absence of protease-resistant prion protein in dementia characterized by neuronal loss and status spongiosus. Acta Neuropathologica. 86(5). 515–7. 2 indexed citations
16.
Pladys, Patrick, et al.. (1993). [Auto-immune idiopathic thrombocytopenic purpura in children. Apropos of 100 cases].. PubMed. 48(3). 181–8. 2 indexed citations
17.
Sutherland, May Kung, L. Wong, Martin J. Somerville, et al.. (1992). Reduction of thyroid hormone receptor c-ERB Aα mRNA levels in the hippocampus of Alzheimer as compared to huntington brain. Neurobiology of Aging. 13(2). 301–312. 27 indexed citations
18.
Lukiw, Walter J., B. Rajendra Krishnan, L. Wong, et al.. (1992). Nuclear compartmentalization of aluminum in Alzheimer's disease (AD). Neurobiology of Aging. 13(1). 115–121. 45 indexed citations
19.
Karlinsky, Harry, J. M. Berg, R Becker, et al.. (1991). A Family with Multiple Instances of Definite, Probable and Possible Early-Onset Alzheimer's Disease. The British Journal of Psychiatry. 159(4). 524–530. 8 indexed citations
20.
Bergeron, C., et al.. (1989). Morphometric analysis of Alzheimer's disease with Lewy bodies.. PubMed. 317. 485–92.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026